Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
338 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Policlinica Privada Instituto de Medicina Nuclear
Bahía Blanca, Buenos Aires, Argentina
- Instituto Alexander Flaming
Buenos Aires, Buenos Aires, Argentina
- Hospital Alvarez
Capital Federal, Buenos Aires, Argentina
- Hospital Britanico de Buenos Aires
Capital Federal, Buenos Aires, Argentina
- Hospital Donacion F. Santojanni
Capital Federal, Buenos Aires, Argentina
- Hospital de Oncologia Maria Curie
Capital Federal, Buenos Aires, Argentina
- Hospital Universitario Austral - Servicio de Oncologia
Pilar, Buenos Aires, Argentina
- Hospital Privado de Comunidad
Córdoba, Mar Del Plata, Argentina
- Complejo Medico de la Policia Federal Argentina "churruca-Visca" - Servicio de Oncologia
Buenos Aires, Argentina
- Hospital General de Agudos "carlos G. Durand" - Servicio de Oncologia
Buenos Aires, Argentina
- Sociedad de Beneficencia Hospital Italiano
Córdoba, Argentina
- Instituto Caici
Rosario, Argentina
- H.I.G.A. Eva Peron
San Martin, Argentina
- Albury Base Hospital
Albury, New South Wales, Australia
- West Albury Barker'S Pharmacy
Albury, New South Wales, Australia
- Department of Medical Oncology-Newcastle Mater Misericordiae Hospital
Waratah, New South Wales, Australia
- Department of Oncology
South Brisbane, Queensland, Australia
- Flinders Medical Centre
Bedford Park, South Australia, Australia
- St. Vincent'S Hospital
Fitzroy, Victoria, Australia
- Pharmatel Fresenius Kabi Pty Ltd.
West Melbourne, Victoria, Australia
- Murray Valley Private Hospital
Wodonga, Victoria, Australia
- Bankstown Lidcombe Hospital - Department of Medical Oncology
Bankstown, Australia
- Royal Hobart Hospital
Hobart, Australia
- Sir Charles Gairdner Hospital
Nedlands, Australia
- Royal North Shore Hospital-Medical Oncology Dept.
St Leonards, Australia
- Border Medical Oncology - Murray Valley Private Hospital
Wodonga, Australia
- Clinical Trials Centre - Wollongong Hospital
Wollongong, Australia
- Instituto Do Cancer Do Ceara
Fortaleza, Ceará, Brazil
- Nucleo de Oncologia Da Bahia
Salvador, Estado de Bahia, Brazil
- Associacao de Combate Ao Cancer de Goias - Hospital
Goiânia, Goiás, Brazil
- Hospital Vera Cruz
Belo Horizonte, Minas Gerais, Brazil
- Hospital Das Clinicas Da Ufpr
Curitiba, Paraná, Brazil
- Pro Onco Centro de Tratamento Oncologico S/c Ltda.
Curitiba, Paraná, Brazil
- Hospital Sao Lucas - Pucrs
Porto Alegre, Rio Grande do Sul, Brazil
- Hospital Sao Lucas-Pucrs
Porto Alegre, Rio Grande do Sul, Brazil
- Santo Andre Diagnostico E Tratamento Ltda
Santo André, São Paulo, Brazil
- Santo Andre Diagnosticos E Tratamentos
Santo André, São Paulo, Brazil
- Santo Andre Diagnosticos E Tratamentos Ltda.
Santo André, São Paulo, Brazil
- Complexo Hospitalar Heliopolis
São Paulo, São Paulo, Brazil
- Conjunto Hospitalar de Sorocaba
São Paulo, São Paulo, Brazil
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- 31 May 2005
- Last update posted
- 15 Jan 2008
- Registered enrollment
- 520
- Registry id
- NCT00080340
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.